383 — Tian An Medicare Share Price
- HK$846.02m
- HK$867.70m
- HK$1.63bn
- 61
- 72
- 38
- 62
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.47 | ||
Price to Tang. Book | 0.47 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.52 | ||
EV to EBITDA | 4.7 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.63% | ||
Return on Equity | 1.59% | ||
Operating Margin | 5.29% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 1,194.15 | 1,463.49 | 1,437.86 | 1,568.82 | 1,627.2 | n/a | n/a | 6.35% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | +106.59 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Tian An Medicare Ltd, formerly China Medical & HealthCare Group Ltd, is an investment holding company principally engaged in the healthcare business. The Company operates its business through six segments. The Healthcare segment is engaged in the operation of hospitals in China. The Eldercare segment is engaged in the property development of independent living units and project management of health campus in China with focus on elderly care and retirement community, which consist of an elderly nursing home, service apartments, independent living units and a commercial area comprising a shopping mall, retail shops and club hall facilities. The Property Development segment is engaged in the development and sale of properties and land. The Property Investment segment is engaged in the leasing of residential and office properties. The Financial Services segment provides loan financial services. The Securities Trading and Investments is engaged in the trading of securities.
Directors
- Sok Un Chong VCH (63)
- Meibao Guo EDR (45)
- Haiying Zhou EDR (50)
- Ching Man Fung SEC (45)
- Hin Wing Lai NED (63)
- Peng Chong Wong NED (74)
- Zhen Zheng NED (48)
- Wing Kuen Wong NID (67)
- Xiaoning Xia NID (56)
- Lai Sum Yang NID (53)
- Jian Zhang NID (71)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 11th, 1989
- Public Since
- August 1st, 1991
- No. of Employees
- 2,626
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,084,635,457

- Address
- 47/F, China Online Centre
- Web
- https://www.tiananmedicare.com.hk/
- Phone
- +852 null31028500
- Auditors
- BDO LTD
Upcoming Events for 383
Dividend For 0383.HK - 0.0200 HKD
China Medical & HealthCare Group Ltd Annual Shareholders Meeting
Similar to 383
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:41 UTC, shares in Tian An Medicare are trading at HK$0.78. This share price information is delayed by 15 minutes.
Shares in Tian An Medicare last closed at HK$0.78 and the price had moved by +14.71% over the past 365 days. In terms of relative price strength the Tian An Medicare share price has outperformed the FTSE Developed Asia Pacific Index by +16.02% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Tian An Medicare dividend yield is 2.56% based on the trailing twelve month period.
Last year, Tian An Medicare paid a total dividend of HK$0.02, and it currently has a trailing dividend yield of 2.56%.Looking ahead, shares in Tian An Medicare are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-27.
Tian An Medicare are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-27. The historic dividend yield on Tian An Medicare shares is currently 2.56%.
To buy shares in Tian An Medicare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.78, shares in Tian An Medicare had a market capitalisation of HK$846.02m.
Here are the trading details for Tian An Medicare:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 383
Based on an overall assessment of its quality, value and momentum Tian An Medicare is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tian An Medicare. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +8.75%.
As of the last closing price of HK$0.78, shares in Tian An Medicare were trading +3.48% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tian An Medicare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tian An Medicare's management team is headed by:
- Sok Un Chong - VCH
- Meibao Guo - EDR
- Haiying Zhou - EDR
- Ching Man Fung - SEC
- Hin Wing Lai - NED
- Peng Chong Wong - NED
- Zhen Zheng - NED
- Wing Kuen Wong - NID
- Xiaoning Xia - NID
- Lai Sum Yang - NID
- Jian Zhang - NID